Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.

Baqi Y, Pillaiyar T, Abdelrahman A, Kaufmann O, Alshaibani S, Rafehi M, Ghasimi S, Akkari R, Ritter K, Simon K, Spinrath A, Kostenis E, Zhao Q, Köse M, Namasivayam V, Müller CE.

J Med Chem. 2018 Sep 27;61(18):8136-8154. doi: 10.1021/acs.jmedchem.7b01768. Epub 2018 Sep 5.

PMID:
30048589
2.

Shortness of breath, what did the CXR show?

Akkari R, Khishfe BF.

Intern Emerg Med. 2017 Sep;12(6):899-900. doi: 10.1007/s11739-016-1593-5. Epub 2016 Dec 30. No abstract available.

PMID:
28039613
3.

Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist.

Hennen S, Wang H, Peters L, Merten N, Simon K, Spinrath A, Blättermann S, Akkari R, Schrage R, Schröder R, Schulz D, Vermeiren C, Zimmermann K, Kehraus S, Drewke C, Pfeifer A, König GM, Mohr K, Gillard M, Müller CE, Lu QR, Gomeza J, Kostenis E.

Sci Signal. 2013 Oct 22;6(298):ra93. doi: 10.1126/scisignal.2004350.

4.

1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.

Koch P, Akkari R, Brunschweiger A, Borrmann T, Schlenk M, Küppers P, Köse M, Radjainia H, Hockemeyer J, Drabczyńska A, Kieć-Kononowicz K, Müller CE.

Bioorg Med Chem. 2013 Dec 1;21(23):7435-52. doi: 10.1016/j.bmc.2013.09.044. Epub 2013 Sep 25.

PMID:
24139167
5.

Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.

Akkari R, Burbiel JC, Hockemeyer J, Müller CE.

Curr Top Med Chem. 2006;6(13):1375-99. Review.

PMID:
16918456
6.

Synthesis of a new insoluble polymer-supported chiral alcohol auxiliary and its first application to nucleophilic addition to ketenes.

Akkari R, Calmes M, Mai N, Rolland M, Martinez J.

J Org Chem. 2001 Aug 24;66(17):5859-65.

PMID:
11511263

Supplemental Content

Loading ...
Support Center